Abstract
The anticoagulation clinics at the University of Virginia Health Sciences Center and the University of California at Davis Medical Center are nurse-practitioner-operated, are affiliated with the general medicine clinic, and rely on portable prothrombin time (PT) monitors that use whole blood and provide timely as well as accurate results reported in PT seconds or as the international normalized ratio (INR). On-site PT/INR testing at these clinics simplifies anticoagulation, mandates direct patient contact, and facilitates primary as well as comprehensive care for patients requiring multispecialty services in large tertiary care centers. Encounters are relatively brief, averaging 19 minutes; 72% of the encounter time involves anticoagulation care and 28% involves primary care. Anticoagulation results using portable PT/INR monitors are safe and accurate based on comparisons with results from clinics relying on standard instruments.
References
Dalen JE, Hirsh J (eds). Third ACCP Consensus Conference on Antithrombotic Therapy. Chest. 1992;102(suppl):303S–549S.
David FB, Estruch MT, Samson-Corvera EB, Voight GC, Tobin JD. Management of anticoagulation in outpatients. Experience with an anticoagulation service in a municipal hospital setting. Arch Intern Med. 1977;137:197–202.
Errichetti AM, Holden A, Ansell J. Management of oral anticoagulant therapy. Experience with an anticoagulation clinic. Arch Intern Med. 1984;144:1966–8.
Bussey HI, Rospond RM, Quandt CM, Clark GM. The safety and effectiveness of long-term warfarin therapy in an anticoagulation clinic. Pharmacotherapy. 1989;9:214–9.
Cohen IA, Hutchinson TA, Kirking DM, Shue ME. Evaluation of pharmacist-managed anticoagulation clinic. J Clin Hosp Pharm. 1985;10:167–75.
McCurdy SA, White RH. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med. 1992;152:589–92.
Becker DM, Humphries JE, Walker FB, DeMong LK, Bopp JS, Acker MN. Standardizing the prothrombin time: calibrating coagulation instruments as well as thromboplastin. Arch Pathol Lab Med. 1993;117:602–5.
White RH, Becker DM, Gunther-Maher MG. Experience using a portable monitor to monitor anticoagulant therapy. South Med J. 1994;87:206–10.
Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation—a multicenter study. Ann Intern Med. 1993;118:511–20.
Fihn SD, McDonell MB, Vermes D, et al. A computerized intervention to improve timing of outpatient follow-up—a multicenter randomized trial in patients treated with warfarin. J Gen Intern Med. 1994;9:131–9.
Hirsh J. Standard monitoring of warfarin in North America: time for a change. Arch Intern Med. 1992;152:257–8.
Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost justification of a clinical pharmacist-managed anticoagulation clinic. Drug Intel Clin Pharm. 1985;19:575–80.
Bussey HI, Rospond RM, Quandt CM, Clark GM. The safety and effectiveness of long-term warfarin therapy in an anticoagulation clinic. Pharmacotherapy. 189;9:214–19.
Author information
Authors and Affiliations
Additional information
Supported in part by VA grants IIR 87-063 and IIR 90-036.
Rights and permissions
About this article
Cite this article
Becker, D.M., DeMong, L.K., Kaplan, P. et al. Anticoagulation therapy and primary care internal medicine. J Gen Intern Med 9, 525–527 (1994). https://doi.org/10.1007/BF02599227
Issue Date:
DOI: https://doi.org/10.1007/BF02599227